Suchergebnisse - "Bekő, Gabriella"

PubPharm (47)

1

Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients : initial case studies and literature review

enthalten in: GeroScience | 2024

von Gopcsa, L. | Réti, M. | Andrikovics, H. | +22

2

Controversies, difficulties and changes in serological confirmatory testing

enthalten in: Orvosi hetilap | 2023

von Zóka, A. | Gönczi, M. | Baráth, A. | +2

3

Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers

enthalten in: Vaccines | 2023

von Matula, Z. | Bekő, G. | Király, V. | +5

4

Diagnosis of neuroborreliosis in the context of local seroprevalence : A chart review study and a methodological overview

enthalten in: Journal of vector borne diseases | 2023

von Baráth, A. | Révész, M. | Gönczi, M. | +2

5

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment : A Pilot Investigational Study

enthalten in: Journal of clinical medicine | 2023

von Szabó, B. | Reményi, P. | Tasnády, S. | +10

6

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm : a prospective, investigational, real-world study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Lakatos, B. | Szabó, B. | Bobek, I. | +13

7

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19 : Two Cases

enthalten in: EJIFCC | 2022

von Papp, E. | Tasnády, S. | Tisza, K. | +2

8

Immune response against the severe acute respiratory syndrome coronavirus 2

enthalten in: Orvosi hetilap | 2022

von Uher, F. | Matula, Z. | Gönczi, M. | +6

9

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy

enthalten in: Vaccines | 2022

von Matula, Z. | Gönczi, M. | Bekő, G. | +4

10

Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Fagyas, M. | Fejes, Z. | Sütő, R. | +13

1
2
3
4
5
Nächster »
[5]